Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC
Titel:
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC
Auteur:
McKeage, Mark J. Kotasek, Dusan Markman, Ben Hidalgo, Manuel Millward, Michael J. Jameson, Michael B. Harris, Dean L. Stagg, Robert J. Kapoun, Ann M. Xu, Lu Hughes, Brett G. M.